OncoTherapy Science, Inc. (TYO:4564)
Japan flag Japan · Delayed Price · Currency is JPY
20.00
0.00 (0.00%)
Aug 6, 2026, 2:00 PM JST

OncoTherapy Science Ratios and Metrics

Millions JPY. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
8,1658,0577,6064,3539,05413,292
Market Cap Growth
1.41%5.92%74.74%-51.92%-31.88%-38.71%
Enterprise Value
6,0765,8726,6613,7558,07711,071
Last Close Price
20.0021.0028.0020.0047.0069.00

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Forward PE
-25.4925.4925.4925.4925.49
PS Ratio
10.119.9710.147.147.9811.53
PB Ratio
3.813.7610.4512.3310.606.72
P/TBV Ratio
3.813.7610.4512.3310.606.72
PEG Ratio
-0.760.760.760.760.76

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/Sales Ratio
7.527.278.886.167.129.60

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Debt / Equity Ratio
-0.98-0.98-1.14-1.49-1.31-0.93
Net Debt / EBITDA Ratio
----1.020.90
Net Debt / FCF Ratio
2.122.121.020.431.400.73
Asset Turnover
0.460.460.740.510.540.38
Inventory Turnover
18.9918.9916.6017.0410.9720.37
Quick Ratio
12.9712.972.851.992.043.70
Current Ratio
13.6613.663.382.282.344.31
Return on Equity (ROE)
-63.44%-63.44%-150.79%-213.42%-78.93%-101.74%
Return on Assets (ROA)
-28.81%-28.81%-49.27%-58.87%-32.98%-42.40%
Return on Capital Employed (ROCE)
-37.00%-37.00%-96.30%-220.50%-122.70%-98.70%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
-11.15%-11.29%-10.71%-29.59%-12.35%-19.34%
FCF Yield
-12.05%-12.21%-10.71%-28.23%-8.81%-19.03%
Buyback Yield / Dilution
-25.69%-25.69%-22.73%-10.45%-2.76%-6.31%